期刊文献+

光动力疗法联合复方倍他米松局部封闭治疗增生性瘢痕疗效观察 被引量:3

Clinical Efficacy of Photodynamic Therapy Combined with Compound Betamethasone for Local Block Treatment of Hypertrophic Scar
下载PDF
导出
摘要 目的:研究光动力疗法联合复方倍他米松注射液局部封闭治疗增生性瘢痕的临床疗效。方法:选取2014年1月-2016年1月笔者科室收治的增生性瘢痕患者72例,随机分为试验组和对照组,每组36例。试验组使用光动力法与复方倍他米松注射液进行联合治疗,对照组仅使用复方倍他米松注射液进行治疗。治疗后以临床总有效率、瘢痕评分、不良反应及复发率作为判定疗效指标。结果:患者性别、年龄、病程、皮损部位、瘢痕增生程度组间比较差异均无统计学意义(P>0.05),治疗后试验组总有效率88.9%,显著高于对照组的55.6%(P<0.05);与对照组比较,试验组患者治疗期间、治疗结束后2个月、治疗结束后1年的温哥华瘢痕评定量表、北卡罗来纳大学瘢痕量表评分均明显降低,差异具有统计学意义(均P<0.05);试验组患者复发率6.25%,明显低于对照组35.00%(P<0.05),且未增加不良反应的发生率(P>0.05)。结论:光动力疗法联合复方倍他米松注射液局部封闭治疗增生性瘢痕疗效明显,可降低复发率,值得临床推广使用。 Objective To evaluate the clinical effect of the combination of the local block therapy of hypertrophic scar with photodynamic therapy and compound betamethasone injection.Methods72patients with hypertrophic scar in our hospital from January2014to January2016were randomly divided into control group or experimental group,36case in each group.Patients in experimental group were treated with photodynamic therapy and compound betamethasone injection,patients in control group only accepted compound betamethasone injection.The clinical total effective rates,scar scale,adverse events and recurrence rate were compared between two groups.Results The total efficiency rate of experimental group was significantly higher than that of control group(88.9%vs55.6%,P<0.05).Compared with the control group,the value of Vancouver scar rating scale and the university of north Carolina scar scale were significantly decreased in experimental group after treatment for4,6,12months respectively(allP<0.05).The rate of recurrence was smaller in experimental group than that of control group(P<0.05),however,there was no statistically significant difference on adverse events between two groups(P>0.05).Conclusion Photodynamic therapy combined with compound betamethasone injection for the local block treatment of hypertrophic scar has a significant clinical effect,and reduces the risk of recurrence.It is worth of widely clinical use.
作者 姚建 苏开新 王海华 郭虎 YAO Jian;SU Kai-xin;WANG Hai-hua;GUO Hu(Department of Burn and Plastic Surgery, Zhuzhou Central Hospital,Zhuzhou 412007,Hunan,China)
出处 《中国美容医学》 CAS 2018年第2期81-83,共3页 Chinese Journal of Aesthetic Medicine
关键词 增生性瘢痕 光动力疗法 复方倍他米松注射液 复发 hypertrophic scar photodynamic therapy compound betamethasone injection recurrence
  • 相关文献

参考文献9

二级参考文献103

  • 1部君萍,张月红.CO_2点阵激光联合糖皮质激素治疗增生性色素疤痕的临床疗效观察[J].中国医疗美容,2013,3(3):65-65. 被引量:9
  • 2李波,赵柏程,周启昌,刘明辉,张轶.彩色多普勒观测醋酸曲安奈德治疗病理性瘢痕前后血流参数变化[J].中国现代医学杂志,2005,15(22):3461-3463. 被引量:3
  • 3滕雯,郝立君,任丽虹,肖志波,王敏,李芍华.595nm Vbeam激光对兔耳增生性瘢痕成纤维细胞增殖的影响[J].中国临床康复,2006,10(24):120-123. 被引量:7
  • 4Gauglitz GG,Korting HC,Pavicic T,et al.Hypertrophic scarring and keloids:pathomechanisms and current and emerging treatment strategies[J].Mol Med,2011,17(1-2):113-125.
  • 5Cai H,Gu Y,Sun Q,et al.Effect of hematoporphyrin monomethyl ether-mediated photodynamic therapy on hypertrophic scar fibroblasts[J].Photodermatol Photoimmunol Photomed,2011,27(2):90-96.
  • 6Moan J,Peng Q.An outline of the hundred-year history of PDT[J].Anticancer Res,2003,23(5A):3591-3600.
  • 7Lang K,Schulte KW,Ruzicka T,et al.Aminolevulinic acid(Levulan)in photodynamic therapy of actinic keratoses[J].Skin Therapy Lett,2001,6(10):1-2.
  • 8Mendoza J,Sebastian A,Allan E,et al.Differential cytotoxic response in keloid fibroblasts exposed to photodynamic therapy is dependent on photosensitiser precursor,fluence and location of fibroblasts within the lesion[J].Arch Dermatol Res,2012,304(7):549-562.
  • 9Saczko J,Chwilkowska A,Kulbacka J,et al.Photooxidative action in cancer and normal cells induced by the use of photofrin in photodynamic therapy[J].Folia Biol(Praha),2008,54(1):24-29.
  • 10Jarvi MT,Niedre MJ,Patterson MS,et al.Singlet oxygen luminescence dosimetry(SOLD)for photodynamic therapy:current status,challenges and future prospects[J].Photochem Photobiol,2006,82(5):1198-1210.

共引文献173

同被引文献32

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部